These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18344753)

  • 1. Effects of central corneal thickness on the efficacy of topical ocular hypotensive medications.
    Johnson TV; Toris CB; Fan S; Camras CB
    J Glaucoma; 2008 Mar; 17(2):89-99. PubMed ID: 18344753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.
    Brandt JD; Beiser JA; Gordon MO; Kass MA;
    Am J Ophthalmol; 2004 Nov; 138(5):717-22. PubMed ID: 15531304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal thickness- and age-related biomechanical properties of the cornea measured with the ocular response analyzer.
    Kotecha A; Elsheikh A; Roberts CR; Zhu H; Garway-Heath DF
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5337-47. PubMed ID: 17122122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes.
    Medeiros FA; Sample PA; Weinreb RN
    Ophthalmology; 2003 Oct; 110(10):1903-8. PubMed ID: 14522761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The measurement of central corneal thickness of normal subjects and glaucomatous patients with optical coherence tomography].
    Liu X; Zeng YF; Huang JJ; Zheng XP; Ling YL; Cai XY
    Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):199-203. PubMed ID: 16643748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central thickness of the cornea in ocular hypertension and open-angle glaucoma].
    Chiseliţă D; Danielescu C; Gagos-Zaharia O; Gherman C
    Oftalmologia; 2007; 51(3):98-103. PubMed ID: 18064964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between parameters of aqueous humor dynamics and the influence of central corneal thickness.
    Gulati V; Ghate DA; Camras CB; Toris CB
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):920-6. PubMed ID: 20881287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of central corneal thickness on the long-term outcome of selective laser trabeculoplasty as primary treatment for ocular hypertension and primary open-angle glaucoma.
    Shazly TA; Latina MA; Dagianis JJ; Chitturi S
    Cornea; 2012 Aug; 31(8):883-6. PubMed ID: 22525783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma.
    Harasymowycz PJ; Papamatheakis DG; Ennis M; Brady M; Gordon KD;
    Cornea; 2007 Jan; 26(1):34-41. PubMed ID: 17198011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of central corneal thickness and corneal curvature radius on the intraocular pressure as measured by different tonometers: noncontact and goldmann applanation tonometers.
    Harada Y; Hirose N; Kubota T; Tawara A
    J Glaucoma; 2008 Dec; 17(8):619-25. PubMed ID: 19092456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
    Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
    Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.
    Toris CB; Zhan G; Fan S; Dickerson JE; Landry TA; Bergamini MV; Camras CB
    J Glaucoma; 2007 Mar; 16(2):189-95. PubMed ID: 17473728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations.
    Wierzbowska J; Łagocka A; Siemiatkowska A; Robaszkiewicz J; Stankiewicz A; Sierdziński J
    Klin Oczna; 2009; 111(10-12):323-6. PubMed ID: 20169887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
    Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
    Katz LJ; Simmons ST; Craven ER
    Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central corneal thickness and measured IOP: a clinical study.
    Phillips LJ; Cakanac CJ; Eger MW; Lilly ME
    Optometry; 2003 Apr; 74(4):218-25. PubMed ID: 12703686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.